This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Ronald Makishima: Innovator in Monoclonal Antibodies
Introduction
Ronald Makishima is a notable inventor in the field of biotechnology, particularly recognized for his work on monoclonal antibodies. His innovative contributions focus on the gastrin hormone, which plays a significant role in various physiological processes.
Latest Patents
Although Ronald Makishima currently holds no patents, his significant invention involves monoclonal antibodies that are selective for the N-termini and C-termini of various forms of the gastrin hormone. This invention provides valuable tools for the detection and quantification of gastrin species, which are essential for monitoring gastrin-mediated diseases or conditions. The assays developed from his work are useful in clinical settings, particularly for diagnosing and treating gastrin-related disorders.
Career Highlights
Ronald Makishima is associated with Cancer Advances, Inc., where he applies his expertise in monoclonal antibody development. His work is pivotal in advancing therapeutic strategies for gastrin-mediated diseases.
Collaborations
Ronald collaborates with Stephen Grimes, contributing to the innovative research environment at Cancer Advances, Inc.
Conclusion
Ronald Makishima's contributions to the field of monoclonal antibodies highlight his commitment to advancing medical science. His work has the potential to significantly impact the diagnosis and treatment of gastrin-mediated conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile